These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 34695076)

  • 1. The inequity of access to health: a case study of patients with gout in one general practice.
    Karu LT; Harwood M; Arroll B; Bryant L; Kenealy T
    N Z Med J; 2021 Oct; 134(1543):51-58. PubMed ID: 34695076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Facilitating equitable prevention and management of gout for Māori in Northland, New Zealand, through a collaborative primary care approach.
    Lawrence A; Scott S; Saparelli F; Greville G; Miller A; Taylor A; Gow P
    J Prim Health Care; 2019 Jul; 11(2):117-127. PubMed ID: 32171354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compounding inequity: a qualitative study of gout management in an urban marae clinic in Auckland.
    Te Karu L; Harwood M; Bryant L; Kenealy T; Arroll B
    J Prim Health Care; 2021 Mar; 13(1):27-35. PubMed ID: 33785108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving gout education from patients' perspectives: a focus group study of Māori and Pākehā people with gout.
    Rolston CJ; Conner TS; Stamp LK; Neha T; Pitama S; Fanning N; Janes R; Judd A; Hudson B; Hegarty RM; Treharne GJ
    J Prim Health Care; 2018 Oct; 10(3):194-200. PubMed ID: 31039932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maori experiences and perceptions of gout and its treatment: a kaupapa Maori qualitative study.
    Te Karu L; Bryant L; Elley CR
    J Prim Health Care; 2013 Sep; 5(3):214-22. PubMed ID: 23998172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gout in Aotearoa New Zealand: are we going to ignore this for another 3 years?
    Dalbeth N; Gow P; Jackson G; Shuker C; Te Karu L; Gerard C; Winnard D
    N Z Med J; 2016 Jan; 129(1429):10-3. PubMed ID: 26914294
    [No Abstract]   [Full Text] [Related]  

  • 7. Allopurinol use in a New Zealand population: prevalence and adherence.
    Horsburgh S; Norris P; Becket G; Arroll B; Crampton P; Cumming J; Keown S; Herbison P
    Rheumatol Int; 2014 Jul; 34(7):963-70. PubMed ID: 24390636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and implementation of a Pacific intervention to increase uptake of urate-lowering therapy for gout: a study protocol.
    Ofanoa M; Ofanoa SM; Heather M; Tu'akoi S; Lutui H; Dalbeth N; Grey C; van der Werf B; Goodyear-Smith F
    Int J Equity Health; 2021 Dec; 20(1):262. PubMed ID: 34949187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National prevalence of gout derived from administrative health data in Aotearoa New Zealand.
    Winnard D; Wright C; Taylor WJ; Jackson G; Te Karu L; Gow PJ; Arroll B; Thornley S; Gribben B; Dalbeth N
    Rheumatology (Oxford); 2012 May; 51(5):901-9. PubMed ID: 22253023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Education Preferences of People With Gout: Exploring Differences Between Indigenous and Nonindigenous Peoples from Rural and Urban Locations.
    Treharne GJ; Richardson AC; Neha T; Fanning N; Janes R; Hudson B; Judd A; Pitama S; Stamp LK
    Arthritis Care Res (Hoboken); 2018 Feb; 70(2):260-267. PubMed ID: 28464485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variation in gout care in Aotearoa New Zealand: a national analysis of quality markers.
    Jackson G; Dalbeth N; Te Karu L; Winnard D; Gow P; Gerard C; Minko N
    N Z Med J; 2014 Oct; 127(1404):37-47. PubMed ID: 25331310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender and Ethnic Inequities in Gout Burden and Management.
    Guillén AG; Te Karu L; Singh JA; Dalbeth N
    Rheum Dis Clin North Am; 2020 Nov; 46(4):693-703. PubMed ID: 32981646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The experience and impact of gout in Māori and Pacific people: a prospective observational study.
    Dalbeth N; House ME; Horne A; Te Karu L; Petrie KJ; McQueen FM; Taylor WJ
    Clin Rheumatol; 2013 Feb; 32(2):247-51. PubMed ID: 23114632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An enquiry into the crippling gout affecting Pacific Islander and Māori men in Western Sydney.
    Coleman W; Spencer D; Wong P; Manolios N
    Int J Rheum Dis; 2021 Nov; 24(11):1394-1401. PubMed ID: 34611996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of gout in a South Auckland general practice.
    Reaves E; Arroll B
    J Prim Health Care; 2014 Mar; 6(1):73-8. PubMed ID: 24624415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Debunking the myths to provide 21st Century management of gout.
    Winnard D; Kake T; Gow P; Barratt-Boyes C; Harris V; Hall DA; Mason H; Merriman T; Dalbeth N;
    N Z Med J; 2008 May; 121(1274):79-85. PubMed ID: 18535649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colchicine prescribing and safety monitoring in patients with gout.
    Ly J; Gow P; Dalbeth N
    N Z Med J; 2007 Nov; 120(1265):U2808. PubMed ID: 18264188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring current and potential roles of Australian community pharmacists in gout management: a qualitative study.
    Counsell AB; Nguyen AD; Baysari MT; Kannangara DRW; McLachlan AJ; Day RO
    BMC Fam Pract; 2018 May; 19(1):54. PubMed ID: 29743018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multimorbidity in Māori and Pacific patients: cross-sectional study in a Dunedin general practice.
    Stokes T; Azam M; Noble FD
    J Prim Health Care; 2018 Mar; 10(1):39-43. PubMed ID: 30068450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperuricaemia and gout in New Zealand rural and urban Māori and non-Māori communities.
    Stamp LK; Wells JE; Pitama S; Faatoese A; Doughty RN; Whalley G; Richards AM; Cameron VA
    Intern Med J; 2013 Jun; 43(6):678-84. PubMed ID: 23279108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.